From the Department of Hematology/Oncology of the University Hospitals Frankfurt, Munich, Dresden, Heidelberg, and Münster, Germany; the Department of Cytogenetics, University of Marburg, Germany; Robert Bosch Klinik Stuttgart, Germany; Deutsche Klinik für Diagnostik Wiesbaden, Germany; Hospital Munich-Schwabing, Germany; and Novartis Pharma AG, Nürnberg, Germany.
Imatinib has pronounced but brief antileukemic activity in advanced Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL). We assessed the prognostic impact of pretreatment disease features and the early bone marrow (BM) response in 68 consecutive patients with Ph+ALL receiving imatinib salvage therapy. A complete hematologic or marrow response was achieved by 92% of patients with BM blasts below 5% on day 14, whereas 62.5% of patients with more than 5% BM blasts on day 14 were nonresponders. Similarly, time to progression (TTP) was superior in patients with a good day 14 response (5.2 versus 0.9 months; P < .0001). Prior complete remission of less than 6 months, white blood cell count of more than 10 x 109/L, circulating peripheral blood blasts at diagnosis, additional Philadelphia chromosomes, or at least 2 Bcr-Abl fusion signals were associated with significantly inferior remission rate and response duration. In patients without poor prognostic features, single-agent imatinib may be appropriate before transplant salvage therapy. Conversely, patients with clinically or cytogenetically defined poor-risk features are candidates for trials of upfront imatinib in combination with other agents.
Impact of blood coagulation and fibrinolytic system changes on early and mid term clinical outcome in patients undergoing stent endografting surgery
Early removal of chest drainage after videothoracoscopic lung biopsy
Positive genetic test led to an early diagnosis of myxoma in a 4-year-old boy
Fatal early acute thrombosis of mechanical mitral prosthesis
‘Double patch and glue’ technique for early repair of posterior post-infarction ventricular septal defect
Early and late results of combined carotid endarterectomy and coronary artery bypass versus isolated coronary artery bypass
Does malperfusion syndrome affect early and mid-term outcome in patients suffering from acute type A aortic dissection
Early clinical experience with the On-X prosthetic heart valve
Off-pump coronary surgery in selected patients: better early outcome but more recurrence of angina
A model to predict the decline of the forced expiratory volume in one second and the carbon monoxide lung diffusion capacity early after major lung resection